HealthDay News — The Trump administration has let go of the last remaining US health officials who oversaw HIV care for more than 1.1 million mothers and children in low-income countries. The move ...

A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...

DAR ES SALAAM: CIVIL Society Organisations (CSOs), health professionals and HIV advocates convened in Dar es Salaam for a high-level dialogue aimed at strengthening the national response to HIV ...

-The Trump administration plans to remove all the members of a presidential advisory council on HIV/AIDS and provided no timeline for replacing them as the government overhauls its prevention and ...

As the Trump administration moves forward with cuts to federal programs, uncertainty looms over initiatives like those ...

As President Donald Trump and Elon Musk’s DOGE team slashes foreign assistance programs, billions of dollars in programs ...

Discover the first-ever national Black-focused HIV Prevention Research Agenda, aiming to end new HIV diagnoses in Black ...

Finding ways to simplify user interfaces to improve accessibility, refine algorithms and explore broader applications of this ...

A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 - but only if between two and ...

The study estimates that nearly 5,00,000 children could die from AIDS-related illnesses and 1 million more could get infected ...

Global deaths from HIV/AIDS and new infections could soar to levels unseen since the start of the century if planned funding ...

A modelling study shows that lenacapavir could end Aids in South Africa by 2032 – but only if between two and four million ...